NDST1 and breast cancer: In breast cancer, miR-149-5p was downregulated by the hyper-methylation of its promoter region and was found to be involved in Adriamycin-resistant breast cancer cells targeting GlcNAc N-deacetylase/N-sulfotransferase-1 (NDST1) [27].